Mood changes and clinical decision making in adolescent patients on isotretinoin therapy for acne vulgaris
© 2023 The Authors. Pediatric Dermatology published by Wiley Periodicals LLC..
Although numerous studies have demonstrated no causal relationship between isotretinoin and depression or suicide, subtle mood changes and idiosyncratic mood symptoms have been reported in patients on isotretinoin treatment for acne vulgaris, and few studies have described the full range of mood symptoms and clinical course after a mood change arises. We reviewed 247 patients, ages 10-25 years, with acne vulgaris on isotretinoin and found that 26/247 (10.5%) patients experienced mood changes, the most common being depressive symptoms, anxiety, aggression, and emotional lability. Regardless of treatment management, 22/25 (88%) patients experienced improvement of mood symptoms to baseline, and 22/25 (88%) were able to complete their isotretinoin course without symptom recurrence. Our findings highlight the importance of monitoring for a broad range of mood changes in patients on isotretinoin, especially those related to a pre-existing mood disorder and including those which do not meet formal criteria for a psychiatric disorder.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Pediatric dermatology - 40(2023), 3 vom: 10. Mai, Seite 494-496 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gradwohl, Kelsey [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acne vulgaris |
|---|
| Anmerkungen: |
Date Completed 24.05.2023 Date Revised 24.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/pde.15324 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355417928 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355417928 | ||
| 003 | DE-627 | ||
| 005 | 20231226064313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pde.15324 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1184.xml |
| 035 | |a (DE-627)NLM355417928 | ||
| 035 | |a (NLM)37037198 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gradwohl, Kelsey |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mood changes and clinical decision making in adolescent patients on isotretinoin therapy for acne vulgaris |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.05.2023 | ||
| 500 | |a Date Revised 24.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. Pediatric Dermatology published by Wiley Periodicals LLC. | ||
| 520 | |a Although numerous studies have demonstrated no causal relationship between isotretinoin and depression or suicide, subtle mood changes and idiosyncratic mood symptoms have been reported in patients on isotretinoin treatment for acne vulgaris, and few studies have described the full range of mood symptoms and clinical course after a mood change arises. We reviewed 247 patients, ages 10-25 years, with acne vulgaris on isotretinoin and found that 26/247 (10.5%) patients experienced mood changes, the most common being depressive symptoms, anxiety, aggression, and emotional lability. Regardless of treatment management, 22/25 (88%) patients experienced improvement of mood symptoms to baseline, and 22/25 (88%) were able to complete their isotretinoin course without symptom recurrence. Our findings highlight the importance of monitoring for a broad range of mood changes in patients on isotretinoin, especially those related to a pre-existing mood disorder and including those which do not meet formal criteria for a psychiatric disorder | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a acne vulgaris | |
| 650 | 4 | |a adolescent | |
| 650 | 4 | |a depression | |
| 650 | 4 | |a isotretinoin | |
| 650 | 4 | |a mood changes | |
| 650 | 7 | |a Isotretinoin |2 NLM | |
| 650 | 7 | |a EH28UP18IF |2 NLM | |
| 650 | 7 | |a Dermatologic Agents |2 NLM | |
| 700 | 1 | |a Verghese, Michelle |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenblatt, Adena E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric dermatology |d 1986 |g 40(2023), 3 vom: 10. Mai, Seite 494-496 |w (DE-627)NLM012965154 |x 1525-1470 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2023 |g number:3 |g day:10 |g month:05 |g pages:494-496 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pde.15324 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2023 |e 3 |b 10 |c 05 |h 494-496 | ||